Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Chang

Showing results (181-190 of 386) with videos related to

Pageof 39
Sort By:
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancers|April 27, 2024
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary StudyJing Liu, Angela Jakary, Javier E Villanueva-Meyer, et al.
Neuro-Oncology Advances|December 8, 2022
Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phaseLauro N Avalos, Tracy L Luks, Tyler Gleason, et al.
Neurosurgery|May 26, 2017
Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with SeizurePatrick M Flanigan, Arman Jahangiri, Ruby Kuang, et al.
Investigational New Drugs|August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsSusan M Chang, John Kuhn, Patrick Wen, et al.
Journal of Neuro-Oncology|August 29, 2018
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastomaJennie W Taylor, Mili Parikh, Joanna J Phillips, et al.
Radiology. Artificial Intelligence|June 12, 2024
The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma MRI DatasetBrandon K K Fields, Evan Calabrese, John Mongan, et al.
Journal of Neuro-Oncology|May 12, 2009
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannomaScott R Plotkin, Chris Halpin, Jaishri O Blakeley, et al.
Neuro-Oncology|February 11, 2004
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomasS Clifford Schold, Demetrius M Kokkinakis, Susan M Chang, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Pageof 39

Showing results (181-190 of 386) with videos related to

Sort By:
Pageof 39
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancers|April 27, 2024
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary StudyJing Liu, Angela Jakary, Javier E Villanueva-Meyer, et al.
Neuro-Oncology Advances|December 8, 2022
Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phaseLauro N Avalos, Tracy L Luks, Tyler Gleason, et al.
Neurosurgery|May 26, 2017
Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with SeizurePatrick M Flanigan, Arman Jahangiri, Ruby Kuang, et al.
Investigational New Drugs|August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsSusan M Chang, John Kuhn, Patrick Wen, et al.
Journal of Neuro-Oncology|August 29, 2018
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastomaJennie W Taylor, Mili Parikh, Joanna J Phillips, et al.
Radiology. Artificial Intelligence|June 12, 2024
The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma MRI DatasetBrandon K K Fields, Evan Calabrese, John Mongan, et al.
Journal of Neuro-Oncology|May 12, 2009
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannomaScott R Plotkin, Chris Halpin, Jaishri O Blakeley, et al.
Neuro-Oncology|February 11, 2004
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomasS Clifford Schold, Demetrius M Kokkinakis, Susan M Chang, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Pageof 39